Copenhagen Bioengineering ApS: Financial statements 2018
CVR: 37640549
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Copenhagen Bioengineering ApS (CVR 37640549) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 261,733 and a net result of DKK 202,059 compared with DKK 51,472 the year before. That is an increase of 397.3% compared with the year before. Equity in the 2018 report amounted to DKK 250,381. The solvency ratio was 75.5%.
- Gross Profit
- DKK 261,733
- Profit/Loss
- DKK 202,059
- Equity
- DKK 250,381
- Total Assets
- DKK 331,431
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 262 t. | 202 t. | 250 t. | - |
| 2017 | - | 53 t. | 51 t. | 48 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Copenhagen Bioengineering ApS has published its annual report for 2017. Gross profit came to DKK 52,632, and the net result was DKK 51,472.
About Copenhagen Bioengineering ApS
Copenhagen Bioengineering ApS is a Danish company of the type Anpartsselskab based in Hårlev, founded in 2016. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Phillip Falkenløve Kaaber and Marco Falkenløve Kaaber. The board consists of Niels Juul Jensen. The company's owners include Strukturforsyningen ApS, Holtug Holding ApS and M.F. Kaaber Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -90,560 and a net result of DKK -210,012 compared with DKK 27,263 the year before. Equity in the 2025 report amounted to DKK 808,561.